Intraoperative Margin Techniques for Esophagogastric Junction Adenocarcinoma: A Controlled Study
NCT ID: NCT07095699
Last Updated: 2025-07-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
314 participants
INTERVENTIONAL
2025-08-15
2028-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions it aims to answer are:
* Is ES non-inferior to intraoperative frozen-section pathology in identifying positive or negative tumor margins?
* Does ES shorten the time needed for margin assessment and reduce the number of additional tissue resections required?
Researchers will compare an ES-assisted surgical arm with a conventional frozen-section arm to see if ES improves margin accuracy, shortens operative time, and increases the rate of complete (R0) tumor removal.
Participants will
* undergo standard AEG resection with randomized assignment to either ES or frozen-section margin checks;
* allow collection of margin tissue samples for ES, frozen-section, and final paraffin pathology;
* attend routine follow-up visits for up to 2 years to monitor for local recurrence.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Esophageal cAncer Screening Trial
NCT04609813
SLND Versus Non-Dissection Following ESD for T1a Stage Esophageal Squamous Cell Carcinoma
NCT06979986
Ajuvant Chemotherapy and Immunotherapy in Patients With Esophageal, Esophageal- Gastric Junction Cancer
NCT04688801
Cytosponge in Surveillance After Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma
NCT06429865
Endoscopic Ultrasound in Diagnosing Cancer in Patients With Localized Stomach Cancer or Esophageal Cancer
NCT00629863
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ES group
ES-assisted surgery
EndoSCell System
EndoSCell Scaner (ES) is a new type of intraoperative cell-level fluorescence-guided imaging technology that can be used for direct and rapid intraoperative tissue cell interpretation. This technology uses a handheld cell microscope system to magnify local tissue by about 1280 times, and can perform rapid real-time scanning and imaging of in vivo or excised ex vivo tissue.
FS Group
Frozen Section without ES scanning
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EndoSCell System
EndoSCell Scaner (ES) is a new type of intraoperative cell-level fluorescence-guided imaging technology that can be used for direct and rapid intraoperative tissue cell interpretation. This technology uses a handheld cell microscope system to magnify local tissue by about 1280 times, and can perform rapid real-time scanning and imaging of in vivo or excised ex vivo tissue.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Including patients with Siewert type II and III AEG; Including patients in cT1 stage (recommended esophageal resection margin distance ≥1.5cm) and cT2 and above (recommended esophageal resection margin distance ≥3cm);
* Plan to receive surgical resection of AEG;
* Patients voluntarily participated in this study and signed the informed consent form;
Exclusion Criteria
* Patients with severe cardiovascular or circulatory system diseases and cannot tolerate surgery;
* Participated in other clinical trials of research drugs or devices in the past month;
* Unable to understand the test requirements or unable to complete the study follow-up plan;
* Pregnant and lactating women;
* Patients who are unable to complete follow-up due to mental illness, cognitive or emotional disorders;
* Subjects who are considered by the researchers to be unsuitable for participating in the study.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fudan University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fenglin Liu
senior doctor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20250308
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.